Risk factors associated with provoked pulmonary embolism
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: This study aimed to investigate the risk factors associated with provoked pulmonary embolism (PE). Methods: This retrospective cohort study included 237 patients with PE. Patients that had transient risk fac tors at diagnosis were classified as having provoked PE, with the remaining patients being classified as having unprovoked PE. The baseline clinical characteristics and factors associated with coagulation were compared. We evaluated the risk factors associated with provoked PE. Results: Of the 237 PE patients, 73 (30.8%) had provoked PE. The rate of respiratory failure and infection, as well as the disseminated intravascular coagulation score and ratio of right ventricular diameter to left ventricular diameter were signifi cantly higher in patients with provoked PE than in those with unprovoked PE. The protein and activity levels associated with coagu lation, including protein C antigen, protein S antigen, protein S activity, anti-thrombin III antigen, and factor VIII, were significantly lower in patients with provoked PE than in those with unprovoked PE. Multivariate analysis showed that infection (odds ratio [OR], 3.2; 95% confidence interval [CI], 1.4 to 7.4) and protein S activity (OR, 0.97; 95% CI, 0.95 to 0.99) were significantly associated with provoked PE. Conclusions: Protein S activity and presence of infection were important factors associated with provoked PE. We should pay attention to the presence of infection in patients with provoked PE.
Abstract
Background/Aims: This study aimed to investigate the risk factors associated with provoked pulmonary embolism (PE). Methods: This retrospective cohort study included 237 patients with PE. Patients that had transient risk fac tors at diagnosis were classified as having provoked PE, with the remaining patients being classified as having unprovoked PE. The baseline clinical characteristics and factors associated with coagulation were compared. We evaluated the risk factors associated with provoked PE. Results: Of the 237 PE patients, 73 (30.8%) had provoked PE. The rate of respiratory failure and infection, as well as the disseminated intravascular coagulation score and ratio of right ventricular diameter to left ventricular diameter were signifi cantly higher in patients with provoked PE than in those with unprovoked PE. The protein and activity levels associated with coagu lation, including protein C antigen, protein S antigen, protein S activity, anti-thrombin III antigen, and factor VIII, were significantly lower in patients with provoked PE than in those with unprovoked PE. Multivariate analysis showed that infection (odds ratio [OR], 3.2; 95% confidence interval [CI], 1.4 to 7.4) and protein S activity (OR, 0.97; 95% CI, 0.95 to 0.99) were significantly associated with provoked PE. Conclusions: Protein S activity and presence of infection were important factors associated with provoked PE. We should pay attention to the presence of infection in patients with provoked PE.
참고문헌 (30)
- Lindblad B, "Autopsy-verified pulmonary embolism in a surgical department: analysis of the period from 1951 to 1988", Br J Surg, 78, pp.849~852 (1991)
- Sandler DA, "Autopsy proven pulmonary embolism in hospital patients: are we detecting enough deep vein thrombosis?", J R Soc Med, 82, pp.203~205 (1989)
- Bagot CN, "Virchow and his triad: a question of attribution", Br J Haematol, 143, pp.180~190 (2008)
- Kucher N., "Clinical practice: deep-vein thrombosis of the upper extremities", N Engl J Med, 364, pp.861~869 (2011)
- Lapner ST, "Diagnosis and management of pulmonary embolism", BMJ, 346, pp.f757~ (2013)
- British Thoracic Society Standards of Care Committee Pulmonary Embolism Guideline Development Group., "British Thoracic Society guidelines for the management of suspected acute pulmonary embolism", Thorax, 58, pp.470~483 (2003)
- Howard LS, "NICE guideline: management of venous thromboembolic diseases and role of thrombophilia testing", Thorax, 68, pp.391~393 (2013)
- Carson JL, "The clinical course of pulmonary embolism", N Engl J Med, 326, pp.1240~1245 (1992)
- Christiansen SC, "Thrombophilia, clinical factors, and recurrent venous thrombotic events", JAMA, 293, pp.2352~2361 (2005)
- Klok FA, "Risk of arterial cardiovascular events in patients after pulmonary embolism", Blood, 114, pp.1484~1488 (2009)
- Sorensen HT, "The risk of a diagnosis of cancer after primary deep venous thrombosis or pulmonary embolism", N Engl J Med, 338, pp.1169~1173 (1998)
- Kearon C, "Comparison of 1 month with 3 months of anticoagulation for a first episode of venous thromboembolism associated with a transient risk factor", J Thromb Haemost, 2, pp.743~749 (2004)
- Levine MN, "Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis", Thromb Haemost, 74, pp.606~611 (1995)
- Schulman S, "A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism:duration of Anticoagulation Trial Study Group", N Engl J Med, 332, pp.1661~1665 (1995)
- Prandoni P, "Deep-vein thrombosis and the incidence of subsequent symptomatic cancer", N Engl J Med, 327, pp.1128~1133 (1992)
- Pinede L, "Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis", Circulation, 103, pp.2453~2460 (2001)
- Cushman M, "Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology", Am J Med, 117, pp.19~25 (2004)
- Huisman MV, "Diagnostic management of acute deep vein thrombosis and pulmonary embolism", J Thromb Haemost, 11, pp.412~422 (2013)
- Chong LY, "Management of venous thromboembolic diseases and the role of thrombophilia testing:summary of NICE guidance", BMJ, 344, pp.e3979~ (2012)
- van der Meer RW, "Right ventricular dysfunction and pulmonary obstruction index at helical CT: prediction of clinical outcome during 3-month follow-up in patients with acute pulmonary embolism", Radiology, 235, pp.798~803 (2005)
- Ghuysen A, "Computed tomographic pulmonary angiography and prognostic significance in patients with acute pulmonary embolism", Thorax, 60, pp.956~961 (2005)
- Taylor FB Jr, "Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation", Thromb Haemost, 86, pp.1327~1330 (2001)
- Levi M., "Current understanding of disseminated intravascular coagulation", Br J Haematol, 124, pp.567~576 (2004)
- D’Angelo A, "Acquired deficiencies of protein S: protein S activity during oral anticoagulation, in liver disease, and in disseminated intravascular coagulation", J Clin Invest, 81, pp.1445~1454 (1988)
- Bucciarelli P, "Risk of venous thromboembolism and clinical manifestations in carriers of antithrombin, protein C, protein S deficiency, or activated protein C resistance: a multicenter collaborative family study", Arterioscler Thromb Vasc Biol, 19, pp.1026~1033 (1999)
- Koster T, "Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis", Lancet, 345, pp.152~155 (1995)
- Wells PS, "Elevated factor VIII is a risk factor for idiopathic venous thromboembolism in Canada: is it necessary to define a new upper reference range for factor VIII?", Thromb Haemost, 93, pp.842~846 (2005)
- Broekmans AW, "Hereditary protein S deficiency and venous thrombo-embolism:a study in three Dutch families", Thromb Haemost, 53, pp.273~277 (1985)
- Levi M, "Disseminated intravascular coagulation in infectious disease", Semin Thromb Hemost, 36, pp.367~377 (2010)
- Engesser L, "Hereditary protein S deficiency: clinical manifestations", Ann Intern Med, 106, pp.677~682 (1987)